Biosynthetic and Metabolic Alterations in Cancer Growth

ISSN: 2211-5536 (Online)
ISSN: 2211-5528 (Print)


Volume 3, 4 Issues, 2014


Download PDF Flyer




Current Angiogenesis

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Dr. Dipak Panigrahy
The Center for Vascular Biology Research and The Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School
Boston, MA
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Biosynthetic and Metabolic Alterations in Cancer Growth

Author(s): Jie Zheng and Peng Gao

Affiliation: Department of Pathology, School of Medicine, Southeast University, Nanjing 210009, People’s Republic of China.

Abstract

Although cancers are derived from human body, their metabolic regulations are different from most normal tissues which mainly reflect on energy and biosynthesis metabolism. In energy metabolism, cancer cells take up glucose and glutamine at a high rate for aerobic glycolysis (Warburg effects). Although aerobic glycolysis does seem wasteful, it is essential for cancer growth in both energy supply and biosynthesis. In biosynthesis, nucleic acid, lipid and protein synthesis are more active in cancer cells than normal cells, but synthetic pathways in cancer cells are different from normal cells, cancer cells prefer to de novo synthesis even though it is not economic. Altered biosynthesis in cancer has challenges, but also opportunities. Understanding the process of cancer biosynthesis will help to develop new approaches in early diagnosis and target therapy of cancer.

Keywords: Biosynthesis, cancer, lipid, mTOR, nucleic acid, protein.

Purchase Online Rights and Permissions

Article Details

Volume: 2
Issue Number: 2
First Page: 149
Last Page: 156
Page Count: 8
DOI: 10.2174/2211552802666140131104038
Advertisement

Related Journals



Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science